Cargando…

Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence

Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma. The two predominant histologic variants of RMS, embryonal and alveolar rhabdomyosarcoma (eRMS and aRMS, respectively), carry very different prognoses. While eRMS is associated with an intermediate prognosis, the 5-year survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jenny J., Kovach, Alexander R., DeMonia, Margaret, Slemmons, Katherine K., Oristian, Kristianne M., Chen, Candy, Linardic, Corinne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363632/ https://www.ncbi.nlm.nih.gov/pubmed/34389744 http://dx.doi.org/10.1038/s41598-021-95355-2

Ejemplares similares

Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.
por: Kubo, K., et al.
Publicado: (1991)

A method to culture human alveolar rhabdomyosarcoma cell lines as rhabdospheres demonstrates an enrichment in stemness and Notch signaling
por: Slemmons, Katherine K., et al.
Publicado: (2021)

Identification and targeting of a HES1‐YAP1‐CDKN1C functional interaction in fusion‐negative rhabdomyosarcoma
por: Kovach, Alexander R., et al.
Publicado: (2022)

Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma
por: Slemmons, Katherine K., et al.
Publicado: (2015)

Oncogenic RAS Mutants Confer Resistance of RMS13 Rhabdomyosarcoma Cells to Oxidative Stress-Induced Ferroptotic Cell Death
por: Schott, Christina, et al.
Publicado: (2015)

MTH1 expression is required for effective transformation by oncogenic HRAS
por: Giribaldi, Maria G., et al.
Publicado: (2015)

Pterostilbene Sensitizes Cisplatin-Resistant Human Bladder Cancer Cells with Oncogenic HRAS
por: Chen, Yi-Ting, et al.
Publicado: (2020)

Rhabdomyosarcomas are oncogene addicted to the activation of AVIL
por: Xie, Zhongqiu, et al.
Publicado: (2022)

Case Report: Sequential postzygotic HRAS mutation and gains of the paternal chromosome 11 carrying the mutated allele in a patient with epidermal nevus and rhabdomyosarcoma: evidence of a multiple-hit mechanism involving HRAS in oncogenic transformation
por: Zuntini, Roberta, et al.
Publicado: (2023)

Retrospective analysis of rhabdomyosarcoma (RMS) in children in a single center
por: Li, Meng, et al.
Publicado: (2018)

Kita Driven Expression of Oncogenic HRAS Leads to Early Onset and Highly Penetrant Melanoma in Zebrafish
por: Santoriello, Cristina, et al.
Publicado: (2010)

MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells
por: Riemondy, Kent, et al.
Publicado: (2015)

Early and Late Induction of KRAS and HRAS Proto-Oncogenes by Reactive Oxygen Species in Primary Astrocytes
por: Messina, Samantha, et al.
Publicado: (2017)

p53 mitigates the effects of oncogenic HRAS in urothelial cells via the repression of MCOLN1
por: Jung, Jewon, et al.
Publicado: (2021)

Receptor Tyrosine Kinases as Therapeutic Targets in Rhabdomyosarcoma
por: Crose, Lisa E. S., et al.
Publicado: (2011)

Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

Characterization of a New Human Embryonal Rhabdomyosarcoma Cell Line, RMS‐GR
por: Fernández, Juan Emilio, et al.
Publicado: (1998)

Baseline Characteristics, Prognostic Factors, and Treatment Outcomes for Adult Patients With Rhabdomyosarcoma (RMS)
por: Rab, Saif ur, et al.
Publicado: (2022)

Epigenetic regulator BMI1 promotes alveolar rhabdomyosarcoma proliferation and constitutes a novel therapeutic target
por: Shields, Cara E., et al.
Publicado: (2021)

Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS
por: Yee, Christopher H., et al.
Publicado: (2019)

Genomic retargeting of p53 and CTCF is associated with transcriptional changes during oncogenic HRas-induced transformation
por: Schwartz, Michal, et al.
Publicado: (2020)

Macroautophagy and the Oncogene-Induced Senescence
por: Grasso, Daniel, et al.
Publicado: (2014)

Correction: Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
por: Odeniyide, Patience, et al.
Publicado: (2022)

Oncogenic role of HMGA2 in fusion-negative rhabdomyosarcoma cells
por: Ouchi, Kazutaka, et al.
Publicado: (2020)

Predicting the effects of rare genetic variants on oncogenic signaling pathways: A computational analysis of HRAS protein function
por: Ali, Sadaqat, et al.
Publicado: (2023)

Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
por: Hinson, Ashley R. P., et al.
Publicado: (2013)

Induction and transmission of oncogene-induced senescence
por: Rattanavirotkul, Nattaphong, et al.
Publicado: (2020)

Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
por: van Erp, Anke E. M., et al.
Publicado: (2017)

Multidrug Resistance Phenotype in the RMS‐GR Human Rhabdomyosarcoma Cell Line Obtained after Polychemotherapy
por: Prados, Jose, et al.
Publicado: (1999)

Mice with an Oncogenic HRAS Mutation are Resistant to High-Fat Diet-Induced Obesity and Exhibit Impaired Hepatic Energy Homeostasis
por: Oba, Daiju, et al.
Publicado: (2017)

Expression of oncogenic HRAS (G12V) causes defects in control of cell size in NIH 3T3 cells
por: DeWitt, Jerry T., et al.
Publicado: (2023)

Differential cooperation of oncogenes with p53 and Bax to induce apoptosis in rhabdomyosarcoma
por: Taylor, Alan C, et al.
Publicado: (2006)

Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands
por: Almazán-Moga, A, et al.
Publicado: (2017)

Outcome and prognostic variables in childhood rhabdomyosarcoma (RMS) with emphasis on impact of FOXO1 fusions in non-metastatic RMS: experience from a tertiary cancer centre in India
por: Ramanathan, Subramaniam, et al.
Publicado: (2023)

Local staging and treatment in extremity rhabdomyosarcoma. A report from the EpSSG‐RMS2005 study
por: Terwisscha van Scheltinga, Sheila E. J., et al.
Publicado: (2020)

Serum depletion induced cancer stem cell-like phenotype due to nitric oxide synthesis in oncogenic HRas transformed cells
por: Monji, Keisuke, et al.
Publicado: (2016)

Caspase-2 regulates oncogene-induced senescence
por: Gitenay, Delphine, et al.
Publicado: (2014)

Oncogenic senescence: a multi-functional perspective
por: Baker, Darren J., et al.
Publicado: (2017)

Metabolic alterations accompanying oncogene-induced senescence
por: Aird, Katherine M, et al.
Publicado: (2014)

Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
por: Randolph, Clinita E., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n669kctdds25p092p32h0fkndi